Elevation Oncology, Inc. - COM (ELEV)

Historical Portfolio Holders from Q2 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
44 M
Holdings value Q1 2024
$226 M
Value change Q1 2024
+$110 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
62
Number of buys Q1 2024
0
Number of sells Q1 2024
-1
Average buys Q1 2024 %
0
Average sells Q1 2024 %
0%
CUSIP
28623U101
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 44 M $226 M +$110 M $5.13 62
2023 Q4 25.8 M $13.9 M -$1.44 M $0.54 31
2023 Q3 28 M $18.6 M -$4.68 M $0.66 40
2023 Q2 31.5 M $47.9 M +$22.1 M $1.52 37
2023 Q1 16.2 M $30.8 M +$3.71 M $1.90 26
2022 Q4 14.4 M $13.7 M +$91.7 K $0.95 26
2022 Q3 14.3 M $16.1 M -$1.45 M $1.13 20
2022 Q2 15 M $21 M -$7.07 M $1.40 22
2022 Q1 18.7 M $47.2 M +$632 K $2.52 27
2021 Q4 18.3 M $110 M -$3.12 M $6.02 34
2021 Q3 15.9 M $123 M -$8.12 M $7.79 21
2021 Q2 16.2 M $217 M +$217 M $13.57 36